Description
PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION
First action · last action
2018-06-08 · 2020-03-23
Transactions
8
First transaction's obligation
$0
Base + all options value (sum of deltas)
$46,254,292
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
6
SDVOSB flag on record
No
NAICS
493110 · GENERAL WAREHOUSING AND STORAGE
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-06-08+$0= $0
- Mod P000012018-07-27+$0= $0
- Mod P000022018-10-16+$0= $0
- Mod P000032018-10-16+$0= $0
- Mod P000042018-11-19+$0= $0
- Mod P000052018-11-27+$0= $0
- Mod P000072019-08-06+$0= $0
- Mod P000082020-03-23+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-06-08 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-07-27 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00002· ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED) | 2018-10-16 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00003· ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED) | 2018-10-16 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00004· ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED) | 2018-11-19 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2018-11-27 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00007· EXERCISE AN OPTION | 2019-08-06 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-03-23 | +$0 | $0 | PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION |
Related awards · 7
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D4VCRL38H9C9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026N0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $19,978 | FY2026 |
| 36C25025P0850 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q517 · PHARMACY SERVICES | $7,485 | FY2025 |
| 36C25625P0370 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · Q517 · PHARMACY SERVICES | $3,996 | FY2025 |
| 36C26025D0008 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $0 | FY2025 |
| 36C26025N0080 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $11,988 | FY2025 |
| 36C24824P0166 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · Q702 · TECHNICAL MEDICAL SUPPORT | $158,346 | FY2024 |
Other recipients under R706 from NAC PRIME VENDOR (36W797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P13D0036 | EXP PHARMACEUTICAL SERVICES CORP. | NAC PRIME VENDOR (36W797) | $0 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36W79718D0002_3600 · retrieved 2026-09-26.